IA Trial Radar | ||
|---|---|---|
O estudo clínico NCT06843512 para Perda de peso, Seleção de alimentos está em recrutamento. Consulte a visualização em cartões do Radar de Estudos Clínicos e as ferramentas de descoberta de IA para ver todos os detalhes. Ou pergunte qualquer coisa aqui. | ||
Um estudo corresponde aos critérios do filtro
Visualização em cartões
Voltar à pesquisa
Universidade Estadual da PensilvâniaIdentifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication 25
Os detalhes do estudo clínico estão disponíveis principalmente em inglês. No entanto, a IA Trial Radar pode ajudar! Basta clicar em 'Explicar o estudo' para visualizar e discutir as informações do estudo no idioma selecionado.
O estudo clínico NCT06843512 é um estudo observacional para Perda de peso, Seleção de alimentos. Seu status atual é: em recrutamento. O estudo começou em 15 de julho de 2025 e pretende incluir 25 participantes. Coordenado por a Universidade Estadual da Pensilvânia e deve ser concluído em 1 de dezembro de 2026. Essas informações foram atualizadas no ClinicalTrials.gov em 10 de setembro de 2025.
Resumo
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences ...Mostrar mais
Título oficial
Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet
Condições médicas
Perda de pesoSeleção de alimentosOutros IDs do estudo
- STUDY00026642
Número NCT
Data de início (real)
2025-07-15
Última atualização postada
2025-09-10
Data de conclusão (estimada)
2026-12
Inscrição (estimada)
25
Tipo de estudo
Observacional
Status
Em recrutamento
Palavras-chave
GLP-1
Weight Loss
Virtual Reality
Food behavior
Weight Loss
Virtual Reality
Food behavior
Braços / Intervenções
| Grupo de participantes/Braço | Intervenção/Tratamento |
|---|---|
N/A | GLP-1 Medication Initiation One visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits. |
Desfecho primário
Desfecho secundário
| Medida de desfecho | Descrição da medida | Prazo |
|---|---|---|
Change from Baseline in Total Weight of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Total Calories of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Energy Density of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Variety of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months |
| Medida de desfecho | Descrição da medida | Prazo |
|---|---|---|
Change in Baseline Weight Watchers Food Noise Score at 3 Months | Based on participant's answers to the WW Food Noise questionnaire; Scale of 1-5, 1 being strongly disagree and 5 being strongly agree; Higher scores mean more food noise | Baseline and 3 months |
Change in Baseline 9-question External Food Cue Responsiveness Questionnaire Score at 3 Months | Answers are on a 1-4 scale with 1 being "Rarely" and 4 being "A lot"; higher scores suggest more external food cue reactivity | Baseline and 3 months |
Change in Baseline Adult Eating Behavior Score at 3 Months | Answers on a 1-5 scale with 1 being "Strongly disagree" and 5 being "Strongly agree"; 8 subscales, high scores indicate greater expression of subscale measure | Baseline and 3 months |
Change in Baseline Three-Factor Eating Questionnaire Score at 3 Months | Rated on a scale of 1-4 with 1 being "Definitely false" and 4 being "Definitely true"; 3 subscales, higher scales on each means greater expression of that behavior | Baseline and 3 months |
Change in Baseline General Food Craving-Trait Scale Score at 3 Months | Rated on a 0-5 scale with 0 being "Never/not applicable" and 5 being "Always"; higher scores mean more food dependent | Baseline and 3 months |
Change in Baseline Buffet Food Liking Scores at 3 Months | Rated on a 0-100 scale with 0 being "Dislike extremely" and 100 being "Like extremely"; high scores mean greater liking of the food | Baseline and 3 months |
Assistente de participação
Critérios de elegibilidade
Idades elegíveis
Adulto, Idoso
Idade mínima
18 Years
Sexos elegíveis
Todos
- Adults (18+) with overweight or obesity (BMI >25 kg/m2)
- Not currently taking an incretin-based medication at baseline
- Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
- Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
- Fluent in English
- Adults (18+) without overweight or obesity
- <18 years of age at time of testing
- Adults not taking a GLP-1 Medication
- Adults taking a compound GLP-1
- Adults on GLP-1 medication for longer than 2 weeks at baseline
- Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
- Not fluent in English
Universidade Estadual da Pensilvânia91 estudos clínicos ativos para explorarResponsável pelo estudo
Travis Masterson, Investigador principal, Assistant Professor and Director of the Health, Ingestive Behavior, and Technology Lab, Penn State University
Contato central do estudo
Contato: Christina M Blackmon, 425-499-8049, [email protected]
1 Locais do estudo em 1 países
Pennsylvania
Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University, State College, Pennsylvania, 16802, United States
Christina M Blackmon, Contato, 425-499-8049, [email protected]
Em recrutamento